Cyclerion Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold CYCN, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
3
Funds holding
$67864
Total value held
Buying
2 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $56942 | 16797 | — | Held |
| 2 | Ubs Group Ag | $10627 | 3135 | +3135 | NEW BUY |
| 3 | Barclays Plc | $295 | 87 | +87 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.